dc.contributor.author | Warren, Anne Y. | |
dc.contributor.author | Massie, Charlie E. | |
dc.contributor.author | Watt, Kate | |
dc.contributor.author | Luko, Katarina | |
dc.contributor.author | Orafidiya, Folake | |
dc.contributor.author | Selth, Luke A. | |
dc.contributor.author | Mohammed, Hisham | |
dc.contributor.author | Chohan, Brinder Singh | |
dc.contributor.author | Menon, Suraj | |
dc.contributor.author | Baridi, Ajoeb | |
dc.contributor.author | Zhao, Wanfeng | |
dc.contributor.author | Escriu, Carlos | |
dc.contributor.author | D'Santos, Clive | |
dc.contributor.author | Taylor, Chris | |
dc.contributor.author | Qureshi, Arham | |
dc.contributor.author | Zecchini, Vincent R. | |
dc.contributor.author | Shaw, Greg L. | |
dc.contributor.author | Dehm, Scott M. | |
dc.contributor.author | Mills, Ian G. | |
dc.contributor.author | Carroll, James S. | |
dc.contributor.author | Tilley, Wayne D. | |
dc.contributor.author | McEwan, Iain J. | |
dc.contributor.author | Baniahmad, Aria | |
dc.contributor.author | Neal, David E. | |
dc.contributor.author | Asim, Mohammad | |
dc.date.accessioned | 2018-09-24T15:10:07Z | |
dc.date.available | 2018-09-24T15:10:07Z | |
dc.date.issued | 2019-09 | |
dc.identifier.citation | Warren , A Y , Massie , C E , Watt , K , Luko , K , Orafidiya , F , Selth , L A , Mohammed , H , Chohan , B S , Menon , S , Baridi , A , Zhao , W , Escriu , C , D'Santos , C , Taylor , C , Qureshi , A , Zecchini , V R , Shaw , G L , Dehm , S M , Mills , I G , Carroll , J S , Tilley , W D , McEwan , I J , Baniahmad , A , Neal , D E & Asim , M 2019 , ' A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer ' , Oncogene , vol. 38 , no. 7 , pp. 1136-1150 . https://doi.org/10.1038/s41388-018-0501-z | en |
dc.identifier.issn | 0950-9232 | |
dc.identifier.other | PURE: 137897930 | |
dc.identifier.other | PURE UUID: 87bbf2d9-786c-46d6-80ee-9166a68bec87 | |
dc.identifier.other | Scopus: 85053771274 | |
dc.identifier.other | Mendeley: 07003e04-de88-3ce2-a344-e96fa777c25b | |
dc.identifier.other | WOS: 000458624900015 | |
dc.identifier.other | PubMed: 30237440 | |
dc.identifier.uri | http://hdl.handle.net/2164/11167 | |
dc.description | We acknowledge support from the National Cancer Research Institute (National Institute of Health Research (NIHR) collaborative study: “Prostate Cancer: Mechanism of Progression and Treatment (PROMPT)” (grant G0500966/75466). This work was funded by a Cancer Research UK program grant (to DEN) and funding from the US Department of Defense (Prostate Cancer Research Program Transformative Impact Award, grant ID W81XWH-13- 2-0093; WDT, SMD and LAS), National Health and medical Research Council (grant ID 1083961; LAS) and PCFA/Cancer Australia/Movember (grant IDs 1012337 and 1043482; WDT and LAS). The research programs of WDT and LAS are supported by the Movember Foundation and the Prostate Cancer Foundation of Australia through the Movember Revolutionary Team Award. This work was also supported by the National Institutes of Health (NIH) grant R01CA174777 to SMD. FO was supported by a PhD project grant from Prostate Cancer UK (S10-10). LAS and MA were supported by a Young Investigator Award from the Prostate Cancer Foundation of the USA. | en |
dc.format.extent | 15 | |
dc.language.iso | eng | |
dc.relation.ispartof | Oncogene | en |
dc.rights | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | prostate cancer | en |
dc.subject | androgen receptor | en |
dc.subject | signalling kinase | en |
dc.subject | transcriptional regulation | en |
dc.subject | DOMAIN | en |
dc.subject | ORIGINATED PROTEIN-KINASE | en |
dc.subject | MITOTIC KINASE | en |
dc.subject | TOPK | en |
dc.subject | GENE | en |
dc.subject | ANTIANDROGEN | en |
dc.subject | RESISTANCE | en |
dc.subject | EXPRESSION | en |
dc.subject | PBK/TOPK | en |
dc.subject | ABIRATERONE | en |
dc.subject | RC0254 Neoplasms. Tumors. Oncology (including Cancer) | en |
dc.subject | Genetics | en |
dc.subject | Molecular Biology | en |
dc.subject | Cancer Research | en |
dc.subject | Cancer Research UK | en |
dc.subject | National Institute for Health Research (NIHR) | en |
dc.subject | G0500966/75466 | en |
dc.subject | Supplementary Data | en |
dc.subject.lcc | RC0254 | en |
dc.title | A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1038/s41388-018-0501-z | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85053771274&partnerID=8YFLogxK | en |
dc.identifier.url | http://www.mendeley.com/research/reciprocal-feedback-between-pdz-binding-kinase-androgen-receptor-drives-prostate-cancer | en |
dc.identifier.vol | 38 | en |
dc.identifier.iss | 7 | en |